Stock SHPH SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shuttle Pharmaceuticals Holdings, Inc.

Equities

SHPH

US8256932034

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
0.4308 USD +0.65% Intraday chart for Shuttle Pharmaceuticals Holdings, Inc. +4.51% -5.32%
Mar. 21 Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 07 Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $2.25 million in funding CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 26.63 7.28
Enterprise Value (EV) 1 18.96 2.904
P/E ratio -6.55 x -1.03 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA -7.44 x -0.49 x
EV / FCF -9.57 x -1.06 x
FCF Yield -10.5% -94.7%
Price to Book 3.47 x 1.8 x
Nbr of stocks (in thousands) 13,586 15,999
Reference price 2 1.960 0.4550
Announcement Date 3/15/23 3/21/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2020 2021 2022 2023
Net sales - - - - -
EBITDA 1 -0.5686 -0.5037 -1.737 -2.548 -5.886
EBIT 1 -0.5866 -0.5095 -1.743 -2.554 -5.892
Operating Margin - - - - -
Earnings before Tax (EBT) 1 -0.6261 -0.8057 -1.152 -3.028 -6.593
Net income 1 -0.6261 -0.8057 -1.152 -3.028 -6.593
Net margin - - - - -
EPS 2 -0.0766 -0.0868 -0.1349 -0.2994 -0.4419
Free Cash Flow 1 -0.5948 - 0.5339 -1.982 -2.749
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 9/16/19 2/11/22 6/3/22 3/15/23 3/21/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2020 2021 2022 2023
Net Debt 1 0.17 1.37 0.57 - -
Net Cash position 1 - - - 7.67 4.38
Leverage (Debt/EBITDA) -0.2941 x -2.723 x -0.3271 x - -
Free Cash Flow 1 -0.59 - 0.53 -1.98 -2.75
ROE (net income / shareholders' equity) 487% - 69.4% -100% -112%
ROA (Net income/ Total Assets) -98.8% - -182% -34.3% -50.4%
Assets 1 0.6341 - 0.6323 8.826 13.07
Book Value Per Share 2 0 -0.1600 -0.1800 0.5600 0.2500
Cash Flow per Share 2 0.0400 0.0100 0.0500 0.6200 0.1600
Capex - 0.01 - - 0.02
Capex / Sales - - - - -
Announcement Date 9/16/19 2/11/22 6/3/22 3/15/23 3/21/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Stock Shuttle Pharmaceuticals Holdings, Inc.
-5.32% 7.25M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.74% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.34% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.07% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.25% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.99% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.77% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-4.42% 205B
PFIZER, INC. Stock Pfizer, Inc.
+2.81% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SHPH Stock
  4. Financials Shuttle Pharmaceuticals Holdings, Inc.